Literature DB >> 10886506

Characterization of a transcription factor binding site, specifically activating MIA transcription in melanoma.

M Golob1, R Buettner, A K Bosserhoff.   

Abstract

We have previously isolated the protein MIA, which is secreted from melanoma cells, and identified highly restricted expression patterns in melanocytic tumors. Preliminary studies of the human MIA gene provided evidence that the promoter is specifically activated in melanoma cells but is silent in nonmelanocytic cells and benign melanocytes. In this study we aimed to identify cis-regulatory promoter elements that mediate promoter activation during malignant transformation of melanocytes. We therefore subcloned 1.4 kb of the murine MIA promoter and a series of 5' deletion constructs into a luciferase reporter plasmid and identified the most active cis-regulatory element between nucleic acids -230 and -130. Cloning oligomeric fragments of this promoter region in front of a minimal TK promoter revealed a 30 bp enhancer element mediating expression of the reporter gene in melanoma cells but not in melanocytes or nonmelanocytic cells. Gel mobility shift assays and southwestern blots led to the identification of specific DNA-protein complexes in melanoma cells. Fine mutational analysis of the cis-regulatory promoter element showed that two critical nucleic acid residues are essential for both transcriptional activity and formation of the band shift complexes. By an initial small-scale affinity purification we were able to isolate a protein approximately 32 kDa in size from melanoma cells, which we refer to as MATF ("melanoma-associated transcription factor"). Our study identified for the first time MATF, a transcription factor that is upregulated or activated during malignant transformation of melanocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886506     DOI: 10.1046/j.1523-1747.2000.00028.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Solution structure and dynamics of melanoma inhibitory activity protein.

Authors:  Julie C Lougheed; Peter J Domaille; Tracy M Handel
Journal:  J Biomol NMR       Date:  2002-03       Impact factor: 2.835

2.  Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype.

Authors:  Ina Poser; Michaela Golob; Reinhard Buettner; Anja K Bosserhoff
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

3.  Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins.

Authors:  J C Lougheed; J M Holton; T Alber; J F Bazan; T M Handel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

4.  Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice.

Authors:  Markus Moser; Anja-Katrin Bosserhoff; Ernst B Hunziker; Linda Sandell; Reinhard Fässler; Reinhard Buettner
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

5.  Promoters with cancer cell-specific activity for melanoma gene therapy.

Authors:  V V Pleshkan; I V Alekseenko; M V Zinovyeva; T V Vinogradova; E D Sverdlov
Journal:  Acta Naturae       Date:  2011-04       Impact factor: 1.845

6.  Gene therapy for advanced melanoma: selective targeting and therapeutic nucleic acids.

Authors:  Joana R Viola; Diana F Rafael; Ernst Wagner; Robert Besch; Manfred Ogris
Journal:  J Drug Deliv       Date:  2013-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.